MYO9A

(redirected from MYR7)

MYO9A

A gene on chromosome 15q22-q23 that encodes a protein belonging to the myosin gene superfamily of motor proteins. MYO9A is a so-called unconventional myosin involved in intracellular movements. It regulates Rho activity in neurones and has a role in regulating neuronal morphology and function.
References in periodicals archive ?
Fitch forecasts annual capex of MYR7 billion over 2018-2019, driven primarily by these two projects.
Fitch Affirms Genting Berhad at 'A-'/Stable
The two class IX myosins in mammals, myosin IXa (Myo9a, myr7) and myosin IXb (Myo9b, myr 5), subsist in diverse variations among species (Newman, 2016).
Evolucion del movimiento como clave para la cognicion humana
IT Services Sales: MYR7.2bn in 2016 to MYR10.0bn in 2019, a CAGR of 7.7%.
New Study: Malaysia Information Technology Report Q1 2016
* Pharmaceuticals: MYR6.60bn (USD2.10bn) in 2013 to MYR7.51bn (USD2.35bn) in 2014; +13.7% in local currency and +12.0% in US dollar terms.
"Malaysia Pharmaceuticals & Healthcare Report Q4 2014" is now available at Fast Market Research
Group profit before tax (PBT) for the year was 12.3 percent higher at MYR8.87bn, compared with the MYR7.90bn in 2012.
Maybank reports record profit
The transactions are seen to boost SME Bank's total financing assets to over MYR10bn within the next three years from MYR7.9bn at present.
-Malaysia's SME Bank plans MYR3bn Islamic bond sales
Conserve has 77 employees and its 2011 revenues are expected to reach MYR7.6m (USD2.4m/EUR1.8m).Country: Malaysia, Sector: Business and Consumer ServicesTarget: Labservice (M) Sdn Bhd, Consolidated Laboratory (M) Sdn BhdBuyer: SGS SAType: Corporate acquisitionStatus: Closed
SGS bolsters Malaysian position with Conserve deal
The brokerage has decreased the target price of the company to MYR6.60 from MYR7.00.
-Affin Investment decreases target price of Lafarge Malayan Cement
The result, which compares to a MYR109.2 million profit earned in the quarter ended March 31, 2005, beat MAS's forecast loss of MYR349 million and was boosted by a "small" MYR7 million profit in March.
Airline Finance News - Asia / Pacific
Swissair is also rumoured to be interested in MAS, and observers have stated that if the deal were based on price, the Swiss carrier would probably emerge as the most favourable bidder, Swissair is believed to be offering as much as MYR7 for each MAS share.
Government report identifies KLM as 'best fit' for Malaysian Airlines
* Pharmaceuticals: MYR6.60bn (USD2.10bn) in 2013 to MYR7.22bn (USD2.25bn) in 2014; +9.3 % in local currency and +7.6% in US dollar terms.
New Market Research Report: Malaysia Pharmaceuticals & Healthcare Report Q1 2015
The two firms are estimated to generate revenues of MYR7.2m (USD2.4m/EUR1.8m) this year.Country: , MalaysiaSector: Food/Beverages/Tobacco, Business and Consumer ServicesTarget: Labservice (M) Sdn Bhd, Consolidated Laboratory (M) Sdn BhdBuyer: SGS SAType: Corporate acquisitionStatus: Closed
Swiss SGS buys Consolidated Laboratory, Labservice in Malaysia
Medical browser ?
Full browser ?